Back to Search
Start Over
Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis
- Source :
- Transplant Infectious Disease. 15:163-170
- Publication Year :
- 2012
- Publisher :
- Wiley, 2012.
-
Abstract
- Background A recent randomized trial demonstrated that 1 year of antiviral prophylaxis for cytomegalovirus (CMV) after lung transplantation is superior to 3 months of treatment for prevention of CMV disease. However, it is uncertain if a shorter duration of prophylaxis might result in a similar rate of CMV disease among select lung transplant (LT) recipients who are at lower risk for CMV disease, based on baseline donor (D) and recipient (R) CMV serologies. Methods We retrospectively assessed incidence, cumulative probability, and predictors of CMV disease and viremia in LT recipients transplanted between July 2004 and December 2009 at our center, where antiviral CMV prophylaxis for 6–12 months is standard. Results Of 129 LT recipients, 94 were at risk for CMV infection based on donor CMV seropositivity (D+) or recipient seropositivity (R+); 14 developed CMV disease (14.9%): 11 with CMV syndrome, 2 with pneumonitis, and 1 with gastrointestinal disease by the end of follow-up (October 2010); 17 developed asymptomatic CMV viremia (18.1%). The cumulative probability of CMV disease was 17.4% 18 months after transplantation. CMV D+/R− recipients who routinely received 1 year of prophylaxis were more likely to develop CMV disease compared with D+/R+ or D−/R+ recipients, who routinely received 6 months of prophylaxis (12/45 vs. 2/25 vs. 0/24, P = 0.005). Recipients who stopped CMV prophylaxis before 12 months (in D+/R− recipients) and 6 months (in R+ recipients) tended to develop CMV disease more than those who did not (9/39 vs. 3/41, P = 0.06). Conclusions On a 6-month CMV prophylaxis protocol, few R+ recipients developed CMV disease in this cohort. In contrast, despite a 12-month prophylaxis protocol, D+/R− LT recipients remained at highest risk for CMV disease.
- Subjects :
- Adult
Male
medicine.medical_specialty
Time Factors
medicine.medical_treatment
Congenital cytomegalovirus infection
Viremia
Lower risk
Antiviral Agents
Gastroenterology
Asymptomatic
Young Adult
Internal medicine
medicine
Humans
Lung transplantation
Aged
Randomized Controlled Trials as Topic
Retrospective Studies
Pneumonitis
Transplantation
business.industry
virus diseases
Retrospective cohort study
Middle Aged
medicine.disease
Infectious Diseases
Cytomegalovirus Infections
Immunology
Female
medicine.symptom
business
Lung Transplantation
Subjects
Details
- ISSN :
- 13982273
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- Transplant Infectious Disease
- Accession number :
- edsair.doi.dedup.....5b51b35f568a8c04e3cb3cf97d75ff93